静止剂治疗用于心血管疾病的初级预防
Fiona C Taylor1, Mark Huffman, Shah Ebrahim
1Department of Noncommunicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
JAMA
|November 27, 2013
概括
在初级预防中,他类药物显著降低了死亡和主要血管事件的风险. 这种降胆固醇疗法不会增加癌症风险,提供了一个安全的心血管保护策略.
科学领域:
- 心血管医学 心血管医学
- 药理学 药理学 是一个学科.
- 预防性心脏病学 预防性心脏病学
背景情况:
- 对心血管疾病 (CVD) 的初级预防对于降低发病率和死亡率至关重要.
- 类药物广泛用于二次预防,但它们在初级预防中的作用需要持续评估.
- 确定用于初级心血管疾病预防的有效和安全干预措施仍然是公共卫生的优先事项.
研究的目的:
- 为了评估他类药物治疗在减少心血管事件的疗效,用于初级预防.
- 评估他类药物的安全性,特别是在癌症等严重不良事件方面.
主要方法:
- 随机对照试验的系统综述和元分析,将他类药物与安慰剂进行比较,用于初级预防.
- 包括报告心血管事件,全因死亡率和包括癌症在内的不良事件的研究.
- 统计分析以确定他类药物对关键结果的综合影响.
主要成果:
- 在初级预防中使用他类药物与所有原因死亡率的显著降低有关.
- 主要的血管事件,包括心肌梗塞和中风,随着他类药物治疗而显著减少.
- 与安慰剂相比,他类药物组的复血管化手术率也较低.
- 在接受他类药物治疗的患者中没有观察到癌症风险增加.
结论:
- 立方体治疗是一种有效的初级预防策略,可以减少心血管事件和死亡率.
- 在初级预防中,他类药物的益处超过了潜在的风险,没有证据表明癌症发病率增加.
- 这些发现支持在特定人群中使用他类药物来降低初级心血管风险.
相关概念视频
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.8K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
01:26Atherosclerosis III: Management
747
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747
01:27Coronary Artery Disease V: Interprofessional Care
450
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
450
01:26Coronary Artery Disease IV: Preventive Measures
891
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
891
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
613
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
613
01:27Peripheral Artery Disease III: Interprofessional Care
659
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
659